ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1397	National Cancer Institute	Html	en	Lymphedema (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling.	cancer treatment 0.423589 PDQ cancer information 0.483377 lymph flow 0.481362 leg 0.408261 left lymph duct 0.48735 white blood cells 0.398624 secondary lymphedema 0.507085 clinical trials 0.422847 cancer information summary 0.440651 clinical trial 0.38593 tiny lymph vessels 0.509598 breast cancer patients 0.459436 sentinel lymph node 0.518746 certified lymphedema therapists 0.498842 breast cancer survivors 0.394173 upper-body exercise 0.39564 NCI PDQ cancer 0.395621 Untreated lymphedema 0.491735 lymph nodes 0.686068 swollen area 0.380684 radiation therapy 0.378654 treatment 0.447311 Lymphedema section 0.47523 lymphedema sleeves 0.47753 severe lymphedema 0.470942	skin 0.4219 Cancer Information Service 0.379239 Primary lymphedema 0.49612 lymph 0.792134 body tissues 0.403337 larger lymph vessels 0.508148 Stage III lymphedema 0.489621 National Cancer Institute 0.439823 arm 0.413813 lymphedema therapist 0.534874 Palliative Care Editorial 0.381473 lymph vessels 0.714976 limb 0.427251 lymphedema 0.932301 certified lymphedema therapist 0.527418 breast cancer 0.483638 Care Editorial Board 0.382648 pressure garment 0.387805 lymphedema increases 0.491902 swollen limb 0.388807 lymph fluid 0.457795 cancer information summaries 0.378678 comprehensive cancer information 0.377712 cancer 0.547119	CLICK HERE
1589	National Cancer Institute	Html	en	Adrenocortical Carcinoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adrenocortical carcinoma.	treatment 0.550891 malignant tumor cells 0.393623 cancer treatment 0.339234 NCI-supported cancer 0.325244 cancer cells 0.380323 Adrenocortical Carcinoma Home 0.328751 adrenal cortex 0.482225 body 0.41124 adrenocortical carcinoma spreads 0.336583 PDQ cancer information 0.400868 adrenal medulla 0.329784 clinical trial search 0.399161 treatment clinical trials 0.346018 affected adrenal gland 0.313913 National Cancer Institute 0.418105 clinical trials 0.816364 adrenal gland 0.62258 High blood pressure 0.300595 Adrenal gland cells 0.329473 normal cells 0.306099 cancer information summary 0.36038 clinical trial 0.576848 Adrenocortical Carcinoma Treatment 0.355819	new treatment 0.426441 nonfunctioning adrenocortical tumor 0.334163 detailed pictures 0.31402 patients 0.305698 adrenocortical carcinoma 0.949806 Recurrent adrenocortical carcinoma 0.379499 adrenocortical carcinoma cells 0.349105 adrenal glands 0.394752 blood 0.322073 nuclear magnetic resonance 0.302225 PDQ summary 0.318647 treatment clinical trial 0.305174 NCI PDQ cancer 0.312561 Treatment Option Overview 0.314325 cancer clinical trials 0.41336 lymph nodes 0.306574 radiation therapy 0.311431 Treatment Editorial Board 0.302427 cancer 0.760261 information 0.413368 standard treatment 0.301619 adrenocortical carcinoma depend 0.345997 positron emission tomography 0.305618	CLICK HERE
1736	National Cancer Institute	Html	en	Surgery to Reduce the Risk of Breast Cancer	A fact sheet that describes mastectomy and salpingo-oophorectomy, two surgeries that may be used to reduce breast cancer risk in women at very high risk, and nonsurgical options.	Surgical Adjuvant Breast 0.509427 breast cancer talk 0.520216 primary breast cancer 0.51166 breast reconstruction surgery 0.528802 radiation-associated breast cancer 0.517996 breast health specialist 0.49326 Breast cancer phenotype 0.510792 Breast Cancer Research 0.511066 early-stage breast cancer 0.509281 breast screening 0.478516 cancer risk reduction 0.514817 bilateral risk-reducing mastectomy 0.474208 bilateral breast cancer 0.543505 ovarian cancer 0.506899 frequent breast cancer 0.518031 clinical breast examinations 0.496735 normal breast functions 0.496662 high risk 0.488512 invasive breast cancer 0.560151 Clinical Oncology 0.486116 primary breast cancers 0.493314 BRCA2 mutation carriers 0.492894 contralateral breast cancer 0.595168 women 0.553369	early breast cancer 0.515841 J. Prophylactic mastectomy 0.474619 appropriate cancer prevention 0.465287 prophylactic bilateral mastectomy 0.491713 breast cancer susceptibility 0.516869 breast cancer surgery 0.554904 prophylactic surgery 0.485463 breast cancers 0.51424 greatest breast cancer 0.535025 breast tissue 0.513481 Cancer Risk Assessment 0.465659 ovarian cancer risk 0.465289 breast surgeons 0.489292 postmenopausal women 0.468075 breast cancer risk 0.685989 breast cancer 0.963464 bilateral prophylactic mastectomy 0.680206 Breast Cancer Trialists 0.509574 prophylactic mastectomy 0.701891 Bilateral prophylactic salpingo-oophorectomy 0.47763 contralateral prophylactic mastectomy 0.553604 strong family history 0.509663 breast cancer-associated mutations 0.511851 et al 0.584443	CLICK HERE
1774	National Cancer Institute	Html	es	Fatiga (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de la fatiga, una afección caracterizada por extremo cansancio e incapacidad para funcionar por la falta de energía, que a menudo se observa como una complicación del cáncer y su tratamiento.	adjuvant chemotherapy 0.23884 Cancer patients as 0.267855 cáncer respalda 0.229838 Breitbart W 0.226519 frase cansancio 0.380985 cancer-related fatigue 0.694477 FossÃ¥ SD 0.231004 critical appraisal 0.229895 Nail LM 0.242438 tripart assessment survey 0.229866 Fatigue Coalition 0.248097 Sin embargo 0.226985 Bower JE 0.361676 National Comprehensive Cancer 0.433137 Supportive Oncology 0.240439 Jacobsen PB 0.225244 Cancer Res 0.298674 Fatigue after treatment 0.230762 Radiat Oncol Biol 0.235818 Supportive Oncology Updates 0.236977 Hematol Oncol Clin 0.226159 Fatigue Symptom Inventory 0.230776 Support Care 0.298981 Ganz PA 0.346159 survivors with persistent 0.230866	Comprehensive Cancer Network 0.433487 patients with 0.336679 Donovan KA 0.225133 Pain Symptom Manage 0.518651 Cella D 0.246025 patients treated with 0.224435 Ancoli-Israel S 0.229262 Oncol Nurs Forum 0.973332 citocinas proinflamatorias 0.262356 Care Cancer 0.446044 Portenoy RK 0.231388 Procrit Study Group 0.227164 menor cansancio 0.370471 breast carcinoma survivors 0.265734 patients receiving 0.226133 Clin Oncol 0.504505 Oncol Biol Phys 0.236851 individual with 0.229384 research literature investigating 0.225358 long-term breast carcinoma 0.246503 early stage breast 0.235969 Lee Fatigue Scale 0.226512 cancer patient 0.800328 término cansancio 0.373768	CLICK HERE
1960	National Cancer Institute	Html	es	Tratamiento del sarcoma uterino (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del sarcoma uterino.	estadios iva 0.401059 sarcoma uterino causa 0.406591 siguientes procedimientos 0.403992 Estadio IA 0.402022 estadio iv 0.408854 cáncer.ampliar cistoscopia 0.401375 siguientes aspectos 0.404454 Estadio IB 0.402046 estadio ii 0.409805 útero forma 0.405141 Estadio IIIB 0.402011 Estadio IIIC 0.402019 estadios ia 0.401093 vía oral 0.40093 Estadio IIIA 0.402062 rayos x 0.401181 ondas sonoras 0.401284	National Cancer Institute 0.400945 estadios iiia 0.401156 siguientes riesgos 0.400687 áreas anormales.ampliar examen 0.402099 Instituto Nacional 0.401682 PDQ Tratamiento 0.411733 ecograma.ampliar ecografía 0.401623 Physician Data Query 0.403425 último panel 0.401341 estadio iii 0.406282 cuello uterino 0.559914 histerectomía abdominal 0.405298 sarcoma uterino 0.996876 cáncer quizás 0.40452 Estadio IVB 0.402 Estadio IVA 0.401945 extirpa tanta masa 0.402241	CLICK HERE
1965	National Cancer Institute	Html	es	Tratamiento del tumor de Wilms y otros tumores renales infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del tumor de Wilms y otros tumores renales infantiles.	carcinoma mioepitelial renal 0.526401 siguientes procedimientos 0.505279 siguientes aspectos 0.505599 efectos secundarios meses 0.505495 siguientes síndromes 0.506829 siguientes razones 0.503795 rayos x 0.510267 niño ayuda 0.504738 estadio v 0.504623 tumores benignos 0.514918 sustancia llamada gadolinio 0.50702 tumores renales 0.951588 tumor renal 0.637779 pelvis renal 0.507303 alta potencia 0.509261 cánceres renales 0.508824 siguientes enfermedades 0.50611 nefroblastomatosis perilobular hiperplásica 0.509412 Antecedentes familiares 0.504021 vejiga almacena 0.505429 siguientes estadios 0.504745 riñón.ampliar ecografía 0.506308 células madre 0.544993 problemas renales 0.514442	adultos jóvenes 0.513748 estadio iv 0.508345 cabo ensayos 0.506023 cuerpo.ampliar anatomía 0.504995 pequeña cantidad 0.51696 estadio ii 0.508321 túbulos renales 0.518212 ondas sonoras 0.510366 efectos tardíos 0.540359 escáner.ampliar exploración 0.503685 PDQ Efectos tardíos 0.519051 Von Hippel-Lindau 0.513101 PDQ Tratamiento 0.517805 determinados cambios 0.504218 nefroma mesoblástico congénito 0.582259 siguientes signos 0.506344 tirosina cinasa 0.506394 siguientes factores 0.505365 siguientes situaciones 0.504547 gen smarcb1 0.504862 células renales 0.823203 Wilms Tumor 0.52815 gran crecimiento 0.51167 Childhood Kidney Cancers 0.504322	CLICK HERE
2104	National Cancer Institute	Html	es	Prevención del cáncer de endometrio (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de endometrio y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	Surgical Adjuvant Breast 0.312551 Obstet Gynecol 0.324802 accessed july 0.303593 Iowa Women Health 0.308818 population-based case-control study 0.304331 available online 0.305054 Cancer Research Fund 0.306547 endometrial carcinoma 0.319197 Breast feeding practices 0.304731 American Cancer Society 0.323044 Prospective Investigation into 0.30657 Disease Control 0.304429 case-control study 0.307735 intentional weight loss 0.305807 risk factors 0.315161 colorectal cancer 0.312231 Cancer Causes Control 0.326606 Natl Cancer Inst 0.357685 Women's Health Study 0.306339 Women's Health Initiative 0.307967 PDQ Prevención 0.303492 Research On Cancer 0.312008 endometrial hyperplasia 0.31494 endometrial cancer 0.992212 Reproductive risk factors 0.308365	European Prospective Investigation 0.306481 investigation into cancer 0.322236 Women's Health 0.310973 endometrial cancer risk 0.612217 Cancer Facts 0.307157 Bowel Project 0.305155 Health Study 0.307565 Nutr Cancer 0.307216 dose-response meta-analysis 0.303563 Cancer Research 0.309943 National Cancer Institute 0.30655 epidemiological studies 0.307756 replacement therapy 0.303602 Breast Cancer Prevention 0.308767 endometrial carcinoma among 0.306561 Clin Oncol 0.303952 breast cancer 0.379165 systematic review 0.305375 PDQ Genetics 0.303535 physical activity 0.307794 Gynecol Cancer 0.308219 Breast Cancer Study 0.308595 National Surgical Adjuvant 0.309763 Women’s Health 0.303756	CLICK HERE
3656	National Cancer Institute	Html	en	David Q. Matus, Ph.D.	David Matus studies cellular invasion--a characteristic behavior of metastatic cancer cells--in an evolutionary context.	colon carcinoma cells 0.575003 anchor cell invasion 0.641108 basement membrane 0.798484 transcription factors 0.55171 cell lines 0.544877 Martindale lab 0.540411 cellular basement membrane 0.610463 basement membranes 0.590872 anchor cell 0.729012 reproductive tract 0.559366 graduate school 0.537018 invasion process 0.549999 deep evolutionary roots 0.554576 different nematode species 0.556072 small translucent worm 0.572459 sea anemones 0.537853 Dr. Matus 0.992838 independent research careers 0.559323 genetic control 0.536692 dense sheet-like layer 0.561929 connective tissue underneath 0.560757 —a systematic method 0.560107 uterine cells 0.552149 Caenorhabditis elegans 0.544264 basic biological processes 0.563833	scientist—while training dolphins 0.567297 evolutionary developmental biology 0.55366 vulval cells 0.554372 academic lineage—a trace 0.553945 individual genes 0.558466 Mark Q. Martindale 0.628065 science fair project 0.55475 Stony Brook University 0.569431 metastatic cancer cells 0.596221 mitotic cells 0.54782 scientific career—and 0.537464 anchor cell dividing 0.581016 invasive cell 0.543064 programmed cell death 0.577561 normal cells 0.556326 New York 0.537757 C. elegans 0.565408 anchor cell invasion—and 0.584387 David Q. Matus 0.656523 Cell Biology Department 0.584431 cellular invasion 0.583572 potential drug targets 0.557542 cell behaviors 0.541546 Dr. Martindale 0.549501	CLICK HERE
15907	National Cancer Institute	Html	es	Laetrilo (amigdalina) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del laetrilo (amigdalina) como tratamiento para personas con cáncer.	siguientes teorías 0.410914 suficiente información 0.405414 Centro Nacional 0.412476 Phaseolus lunatus 0.410368 New Hampshire Avenue 0.408624 Drug Administration 0.405353 NCI Best Case 0.416678 fase i 0.407749 datos bibliográficos pubmed 0.409348 largo plazo 0.408034 siguientes preguntas 0.406283 vitamina b17 0.411219 cuáles tipos 0.408099 vitamina c 0.408062 vitamina a 0.409071 siguientes riesgos 0.407854 seguro médico 0.405074 Instituto Nacional 0.512438	Salud Complementaria 0.418716 Visuals Online 0.406445 siguientes resultados 0.443523 complementarias revisa 0.408971 Physician Data Query 0.437362 siguientes causas 0.409284 Estados Unidos 0.980672 enzimas pancreáticas 0.42962 Corte Suprema 0.408891 libre uso 0.407165 determinadas frutas 0.407416 página manejo 0.406016 ¿El tratamiento 0.415719 ¿Los beneficios 0.405473 juntos cam 0.405199 Series Program 0.405225 medicina complementaria 0.651404	CLICK HERE
16717	National Cancer Institute	Html	en	Cancer Clinical Trials at the National Institutes of Health Clinical Center	Information about cancer clinical trials at the NIH Clinical Center in Bethesda, Maryland.	cancer treatment 0.534356 better understanding 0.369317 clinical program 0.414778 eligibility criteria 0.37194 health insurance 0.371915 novel cancer treatment 0.457878 International patients 0.371646 health care provider 0.502194 clinical trial experience 0.462664 clinical teams 0.407146 NIH physicians 0.420773 Patients page 0.377331 NCI clinic 0.401655 open trials 0.377021 in-house cancer center 0.477433 Patient Self-Referral Form 0.427003 unique hospital 0.366285 clinical trials 0.623234 treatment services 0.380122 health care providers 0.57596 approach fosters interaction 0.418119 National Institutes 0.375152 clinical trial 0.527278 contact information 0.370247 CCR clinical trials 0.482065	patients 0.409802 cancer patients 0.399962 standard treatment options 0.440025 trial’s eligibility 0.38116 related research 0.378808 patient care units 0.440886 United States 0.412623 largest hospital 0.37768 cancer research 0.528759 NIH Clinical Center 0.949828 National Cancer Institute 0.460111 NCI research team 0.453825 Clinical Research Referral 0.467688 Developmental Therapeutics Clinic 0.698646 advanced cancer 0.386466 trial information 0.38805 new treatments 0.372193 NCI principal investigator 0.437174 patient treatment plans 0.430619 compassionate doctors 0.368527 care specialists 0.389607 medical care 0.431584 scientific resources 0.368533 trial summary 0.38584	CLICK HERE